Book Excerpt from Lucky Planet

In the book's prologue, author David Waltham compares a fictitious planet to Earth, highlighting the biologically supportive luck that our planet has enjoyed.

Written byDavid Waltham
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

BASIC BOOKS, APRIL 2014Far beyond the range of any telescope humanity will ever possess lies the doomed planet Nemesis. Nemesis, a near-twin to our own world, is named after the ancient Greek goddess responsible for the rebalancing of undeserved good fortune. As befits this name, Nemesis has been on a lucky roll far longer than any world could reasonably expect, but her streak of good fortune has come to an end.

Nemesis is dying. The immense herds that once swarmed across her vast plains are gone forever. The huge beasts that swam her clear, blue ocean waters are now extinct, and the previously verdant rain forests of her equatorial regions have withered and died. A beautiful and complex biosphere has vanished, leaving bacteria and a few species of worm as meager representatives of the multifarious life-forms that once made Nemesis the biological pinnacle of her galaxy.

When Nemesis first formed she was a duplicate of early earth in almost every way. Most of her subsequent history, too, was strikingly similar to that of our own planet. Both of these initially sterile, overheated hellholes transformed into vibrant, microbe-infested globes within a few hundred million years of their ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies